Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-3206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

A Novel Nuclear Role for the Vav3 Nucleotide Exchange Factor in Androgen Receptor Coactivation in Prostate Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Characterization of a Prostate- And Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2011English

The Androgen Receptor and Prostate Cancer Invasion

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2006English

Androgen Receptor Corepressors and Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

Looking Beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer

Advances in Andrology
2014English

A Novel Nonsense Mutation in Androgen Receptor Confers Resistance to CYP17 Inhibitor Treatment in Prostate Cancer

Oncotarget
Oncology
2016English

Treatment of Androgen‐Independent Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy